{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:38:48Z","timestamp":1782167928170,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.virol.2023.109888","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T16:09:21Z","timestamp":1695398961000},"page":"109888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development of reverse genetic tools to study Chapare and Machupo viruses"],"prefix":"10.1016","volume":"588","author":[{"given":"Shilpi","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punya","family":"Shrivastava-Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-1785","authenticated-orcid":false,"given":"C\u00e9sar G.","family":"Albari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.109888_bib1","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/JVI.00276-09","article-title":"Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing","volume":"83","author":"Albari\u00f1o","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib2","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/JVI.02556-10","article-title":"Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence","volume":"85","author":"Albari\u00f1o","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.virol.2015.06.013","article-title":"Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein","volume":"484","author":"Albari\u00f1o","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109888_bib4","first-page":"329","article-title":"[Preclinical assay of candid #1 vaccine against Argentine Hemorrhagic Fever made in Argentina]","volume":"65","author":"Ambrosio","year":"2005","journal-title":"Medicina"},{"key":"10.1016\/j.virol.2023.109888_bib5","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1128\/JVI.01144-12","article-title":"Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth","volume":"86","author":"Bergeron","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v10110655","article-title":"Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays","volume":"10","author":"Cai","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.109888_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2008.10.016","article-title":"Genetic diversity among Bolivian arenaviruses","volume":"140","author":"Cajimat","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2023.109888_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3201\/eid2808.211787","article-title":"Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies(1)","volume":"28","author":"Cheng","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000047","article-title":"Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia","volume":"4","author":"Delgado","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2023.109888_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: a systematic review and meta-analysis","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.virol.2011.01.013","article-title":"Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies","volume":"411","author":"Emonet","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109888_bib13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease","volume":"85","author":"Emonet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101589","article-title":"Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: a cluster analysis","volume":"36","author":"Escalera-Antezana","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109888_bib16","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1038\/s41598-017-04889-x","article-title":"An attenuated Machupo virus with a disrupted L-segment intergenic region protects Guinea pigs against lethal Guanarito virus infection","volume":"7","author":"Golden","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2023.109888_bib17","article-title":"Inhibition of arenaviruses by combinations of orally available approved drugs","volume":"65","author":"Herring","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2023.109888_bib18","series-title":"Fields Virology","author":"Howley","year":"2021"},{"key":"10.1016\/j.virol.2023.109888_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4269\/ajtmh.1966.15.103","article-title":"Isolation of Machupo virus from wild rodent Calomys callosus","volume":"15","author":"Johnson","year":"1966","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2023.109888_bib20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02615-15","article-title":"Machupo virus expressing GPC of the Candid#1 vaccine strain of Junin virus is highly attenuated and immunogenic","volume":"90","author":"Koma","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib21","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1128\/JVI.00019-09","article-title":"Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers","volume":"83","author":"Lan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2007.10.016","article-title":"Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers","volume":"372","author":"Lee","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109888_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01537-21","article-title":"Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)","volume":"9","author":"Lo","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virol.2023.109888_bib24","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa2110339","article-title":"Chapare hemorrhagic fever and virus detection in rodents in Bolivia in 2019","volume":"386","author":"Loayza Mafayle","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.109888_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4269\/ajtmh.1964.13.620","article-title":"Epidemic hemorrhagic fever in Bolivia. I. A preliminary report of the epidemiologic and clinical findings in a new epidemic area in South America","volume":"13","author":"Mackenzie","year":"1964","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2023.109888_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4939-3387-7_17","article-title":"Reverse genetics approaches to control arenavirus","volume":"1403","author":"Martinez-Sobrido","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2023.109888_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v8070197","article-title":"Reporter-expressing, replicating-competent recombinant arenaviruses","volume":"8","author":"Martinez-Sobrido","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.109888_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1473-3099(19)30291-9","article-title":"Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis","volume":"19","author":"McMullan","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","article-title":"In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit","volume":"160","author":"Noshi","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.109888_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003212","article-title":"Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials","volume":"9","author":"Olschlager","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2023.109888_bib32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1099\/vir.0.051102-0","article-title":"Arenavirus reverse genetics for vaccine development","volume":"94","author":"Ortiz-Riano","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coviro.2014.02.007","article-title":"Epidemiology and pathogenesis of Bolivian hemorrhagic fever","volume":"5","author":"Patterson","year":"2014","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.virol.2023.109888_bib34","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1128\/JVI.01007-14","article-title":"A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of Machupo virus","volume":"88","author":"Patterson","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib35","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/JVI.02925-13","article-title":"Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (alphabeta\/gamma) receptor double knockout mice","volume":"88","author":"Patterson","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.109888_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/oxfordjournals.aje.a121631","article-title":"Hemorrhagic fever in cochabamba, Bolivia, 1971","volume":"99","author":"Peters","year":"1974","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2023.109888_bib37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavirin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.virol.2006.01.012","article-title":"Rescue of the prototypic Arenavirus LCMV entirely from plasmid","volume":"350","author":"Sanchez","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109888_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102001","article-title":"Bolivian hemorrhagic fever: a narrative review","volume":"40","author":"Silva-Ramos","year":"2021","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.virol.2023.109888_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2016.10.007","article-title":"Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems","volume":"136","author":"Welch","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.109888_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2017.10.008","article-title":"Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus","volume":"147","author":"Welch","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.109888_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/v13071255","article-title":"Screening and identification of Lujo virus inhibitors using a recombinant reporter virus platform","volume":"13","author":"Welch","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.109888_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01014-20","article-title":"Development of reverse genetics for the prototype new World Mammarenavirus Tacaribe virus","volume":"94","author":"Ye","year":"2020","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223002076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223002076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T10:55:09Z","timestamp":1730458509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223002076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":44,"alternative-id":["S0042682223002076"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.109888","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of reverse genetic tools to study Chapare and Machupo viruses","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.109888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109888"}}